Theriva Biologics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TOVX and other ETFs, options, and stocks.About TOVX
Theriva Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-020 and SYN-004.
CEOSteven A. Shallcross
CEOSteven A. Shallcross
Employees22
Employees22
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2001
Founded2001
Employees22
Employees22
TOVX Key Statistics
Market cap8.21M
Market cap8.21M
Price-Earnings ratio-0.04
Price-Earnings ratio-0.04
Dividend yield—
Dividend yield—
Average volume3.24M
Average volume3.24M
High today$0.2576
High today$0.2576
Low today$0.1983
Low today$0.1983
Open price$0.1999
Open price$0.1999
Volume6.84M
Volume6.84M
52 Week high$2.08
52 Week high$2.08
52 Week low$0.198
52 Week low$0.198
Stock Snapshot
Theriva Biologics(TOVX) stock is priced at $0.24, giving the company a market capitalization of 8.21M. It carries a P/E multiple of -0.04.
On 2025-12-04, Theriva Biologics(TOVX) stock traded between a low of $0.20 and a high of $0.26. Shares are currently priced at $0.24, which is +23.2% above the low and -5.1% below the high.
The Theriva Biologics(TOVX)'s current trading volume is 6.84M, compared to an average daily volume of 3.24M.
In the last year, Theriva Biologics(TOVX) shares hit a 52-week high of $2.08 and a 52-week low of $0.20.
In the last year, Theriva Biologics(TOVX) shares hit a 52-week high of $2.08 and a 52-week low of $0.20.
People also own
Based on the portfolios of people who own TOVX. This list is generated using Robinhood data, and it’s not a recommendation.